Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	2006 - 2007
Period Ending	Jul '25 Jul 23, 2025	Jun '12 Jun 30, 2012	Jun '11 Jun 30, 2011	Jun '10 Jun 30, 2010	Jun '09 Jun 30, 2009	Jun '08 Jun 30, 2008	2006 - 2007
Market Capitalization	6	6	2	3	-	-	Upgrade
Market Cap Growth	242.86%	242.86%	-35.67%	-	-	-	Upgrade
Enterprise Value	-	6	2	3	-	-	Upgrade
Last Close Price	0.02	0.12	0.04	0.06	-	-	Upgrade
PB Ratio	-48.00	-48.21	-17.43	24.64	-	-	Upgrade
P/TBV Ratio	-	-	-	24.64	-	-	Upgrade
Debt / Equity Ratio	-0.91	-0.91	-1.12	0.96	0.09	-	Upgrade
Quick Ratio	0.14	0.14	0.02	0.07	0.22	117.98	Upgrade
Current Ratio	0.20	0.20	0.22	1.68	9.48	130.25	Upgrade
Return on Equity (ROE)	-	-	-4207.28%	-334.35%	-241.15%	-51.21%	Upgrade
Return on Assets (ROA)	-150.71%	-150.71%	-99.32%	-153.92%	-135.39%	-31.91%	Upgrade
Return on Capital (ROIC)	-13449.13%	-13449.13%	-114.34%	-160.74%	-138.08%	-32.01%	Upgrade
Earnings Yield	-1.20%	-1.19%	-12.05%	-29.45%	-	-	Upgrade
Buyback Yield / Dilution	-0.18%	-0.18%	2.97%	9.71%	-0.42%	-16.80%	Upgrade

Updated Mar 5, 2013. Source: S&P Global Market Intelligence. Standard template. Financial Sources.